Bio-Techne Corp [TECH] Investment Guide: What You Need to Know

Bio-Techne Corp’s filing revealed that its Director Nusse Roeland unloaded Company’s shares for reported $0.8 million on Mar 07 ’24. In the deal valued at $76.98 per share,10,400 shares were sold. As a result of this transaction, Nusse Roeland now holds 43,097 shares worth roughly $2.99 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, Nusse Roeland sold 8,939 shares, generating $717,959 in total proceeds. Upon selling the shares at $80.32, the Director now owns 51,872 shares.

Before that, Kummeth Charles R. sold 80,000 shares. Bio-Techne Corp shares valued at $7,069,024 were divested by the Chief Executive Officer at a price of $88.36 per share. As a result of the transaction, Kummeth Charles R. now holds 1,258,766 shares, worth roughly $87.37 million.

Scotiabank initiated its Bio-Techne Corp [TECH] rating to a Sector outperform in a research note published on February 08, 2024; the price target was $80. A number of analysts have revised their coverage, including Stifel’s analysts, who decreased its forecast for the stock in early February from “a Buy” to “a Hold”. UBS began covering TECH with “Buy” recommendation on December 07, 2023. William Blair started covering the stock on August 28, 2023. It rated TECH as “an Outperform”.

Price Performance Review of TECH

On Monday, Bio-Techne Corp [NASDAQ:TECH] saw its stock fall -1.39% to $69.41. Over the last five days, the stock has lost -2.92%. Bio-Techne Corp shares have fallen nearly -10.04% since the year began. Nevertheless, the stocks have fallen -3.68% over the past one year. While a 52-week high of $89.91 was reached on 03/08/24, a 52-week low of $51.79 was recorded on 02/02/24. SMA at 50 days reached $71.35, while 200 days put it at $72.44. A total of 0.77 million shares were traded, compared to the trading of 1.18 million shares in the previous session.

Levels Of Support And Resistance For TECH Stock

The 24-hour chart illustrates a support level at 68.41, which if violated will result in even more drops to 67.40. On the upside, there is a resistance level at 70.62. A further resistance level may holdings at 71.82. The Relative Strength Index (RSI) on the 14-day chart is 42.72, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.37, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 81.62%. Stochastics %K at 23.06% indicates the stock is a holding.

How much short interest is there in Bio-Techne Corp?

A steep rise in short interest was recorded in Bio-Techne Corp stocks on Mar 15, 2024, growing by 0.37 million shares to a total of 5.1 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 4.73 million shares. There was a rise of 7.25%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 4.21% of the overall stock float, the days-to-cover ratio (short ratio) rose to 4.7.

Most Popular